Hyperglycemia-Induced Secretion of Endothelial Heparanase Stimulates a Vascular Endothelial Growth Factor Autocrine Network in Cardiomyocytes That Promotes Recruitment of Lipoprotein Lipase
Author(s) -
Dahai Zhang,
Andrea Wan,
Amy P. Chiu,
Ying Wang,
Fulong Wang,
Katharieumaier,
Nathaniel Lal,
Michael J. Bround,
James D. Johnson,
Israël Vlodavsky,
Brian Rodrigues
Publication year - 2013
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.113.302222
Subject(s) - heparanase , autocrine signalling , medicine , endocrinology , vascular endothelial growth factor , lipoprotein lipase , vascular endothelial growth factor a , biology , heparin , heparan sulfate , adipose tissue , receptor , vegf receptors
During diabetes mellitus, coronary lipoprotein lipase increases to promote the predominant use of fatty acids. We have reported that high glucose stimulates active heparanase secretion from endothelial cells to cleave cardiomyocyte heparan sulfate and release bound lipoprotein lipase for transfer to the vascular lumen. In the current study, we examined whether heparanase also has a function to release cardiomyocyte vascular endothelial growth factor (VEGF), and whether this growth factor influences cardiomyocyte fatty acid delivery in an autocrine manner.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom